Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06457984

Effects of Selenium Towards Type 2 Diabetes

Effects of Selenium Nutritional Supplement of Glucose, Nutritional Status, and Clinical Outcome Among Type 2 Diabetes Patients

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

According to the prevalence of non-communicable chronic diseases and aging population characteristics, this study is exploring the coexist effects combined with various dimensions: nutritional functions, metabolic homeostasis, inflammation and immunity by the selenium supplementation among type 2 diabetes, which based on insulin resistance, beta-cell function disorders, and body metabolic homeostasis disorders of the mechanism of type 2 diabetes by lifecycle so that could provide with a totally new and safe nutritional method for type 2 diabetes prevention and diagnosis.

Detailed description

This study will last 16 weeks. There will be 300 subjects enrolled by random lottery methods in this randomized double-blind placebo-controlled clinical study by control group, low dose group and high dose group. During the study processing, follow-up visit by call, questionnaires, blood and stool collection, and functional testing will appear. Statistical analysis would be analysis according to the actual outcome of study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSelenium nutritional supplementationSelenium yeast, as a safe from supplementation, could be a new nutritional intervention for lifecycle regulation of type 2 diabetes.

Timeline

Start date
2024-06-15
Primary completion
2024-06-15
Completion
2025-05-07
First posted
2024-06-13
Last updated
2024-06-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06457984. Inclusion in this directory is not an endorsement.